Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: A randomized trial

Autoria(s): Aichinger, Gerald; Ehrlich, Hartmut; Aaskov, John; Fritsch, Sandor; Thomasser, Christiane; Draxler, Wolfgang; Wolzt, Michael; Muller, Markus; Pinl, Fritz; Van Damme, Pierre; Hens, Annick; Levy, Jack; Portsmouth, Daniel; Holzer, Georg; Kistner, Otfried; Kreil, Thomas; Barrett, P. Noel
Data(s)

2011
Identificador

http://eprints.qut.edu.au/52301/
Publicador

Elsevier Ltd
Relação

DOI:10.1016/j.vaccine.2011.09.125

Aichinger, Gerald, Ehrlich, Hartmut, Aaskov, John, Fritsch, Sandor, Thomasser, Christiane, Draxler, Wolfgang, Wolzt, Michael, Muller, Markus, Pinl, Fritz, Van Damme, Pierre, Hens, Annick, Levy, Jack, Portsmouth, Daniel, Holzer, Georg, Kistner, Otfried, Kreil, Thomas, & Barrett, P. Noel (2011) Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: A randomized trial. Vaccine, 29(50), pp. 9376-9384.
Fonte

Faculty of Health; Institute of Health and Biomedical Innovation
Palavras-Chave #060000 BIOLOGICAL SCIENCES #070000 AGRICULTURAL AND VETERINARY SCIENCES #110000 MEDICAL AND HEALTH SCIENCES #Ross River virus, Ross River virus vaccine, Vero cell culture-derived vaccine, Epidemic polyarthritis, RRV, Clinical trial
Tipo

Journal Article
Acesso ao item digital